SAN DIEGO, June 6, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of UroGen Pharma Ltd. (NASDAQ: URGN) securities between July 27, 2023 and May 15, 2025, inclusive (the "Class Period"), have until July 28, 2025 to seek...
Hence then, the article about urgn investor deadline urogen pharma ltd investors with substantial losses have opportunity to lead class action lawsuit was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( URGN INVESTOR DEADLINE: UroGen Pharma Ltd. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit )
Also on site :
- Astros Option Mike Burrows
- 6,000-year-old broken ribs discovered in Syria may be one of the oldest known cases of child abuse in the world
- This Massive Hisense U7 QLED TV Is 43% Off, Its Lowest Price Ever